BeiGene, Ltd. ( BGNE) - Stock Earnings
Stock symbol BGNE is outdated, potentially delisted? Maybe it is available on other exchange?
BGNE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -251.2 million USD | 751.7 million USD |
| 2024Q2 | -120.4 million USD | 929.2 million USD |
| 2024Q3 | -121.4 million USD | 1.0 billion USD |
BGNE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -1.4 billion USD | 1.2 billion USD |
| 2022 | -2.0 billion USD | 1.4 billion USD |
| 2023 | -881.7 million USD | 2.5 billion USD |
BGNE
Price: $184.71
52 week price:
Earnings Per Share: -8.19 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Cayman Islands
Volume: 346500
Ebitda: 116.2 millionMarket Capitalization: 20.2 billion